{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:00:11Z","timestamp":1787317211320,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.4158\/ep-2017-0116","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T15:23:43Z","timestamp":1510845823000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort"],"prefix":"10.1016","volume":"24","author":[{"given":"Jennifer J.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2017-0116_bb0010","unstructured":"GatesGJ.How many people are lesbian, gay, bisexual, and transgender? Williams Inst.Available at: https:\/\/williamsinstitute.law.ucla.edu\/wp-content\/uploads\/Gates-How-Many-People-LGBT-Apr-2011.pdf. Accessed December 4, 2017."},{"key":"10.4158\/EP-2017-0116_bb0015","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0116_bb0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4158\/EP161727.OR","article-title":"Prevalence and types of gender-affirming surgery among a sample of transgender endocrinology patients prior to state expansion of insurance coverage","volume":"23","author":"Kailas","year":"2017","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2017-0116_bb0025","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision: a review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"key":"10.4158\/EP-2017-0116_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgenderism"},{"key":"10.4158\/EP-2017-0116_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15532739.2017.1290566","article-title":"Is a lower dose of cyproterone acetate as effective at testosterone suppression in transgender women as higher doses?","volume":"18","author":"Fung","year":"2017","journal-title":"Int J Transgenderism"},{"key":"10.4158\/EP-2017-0116_bb0040","unstructured":"De BlokCJ.Breast development modest with cross-sex hormonal treatment in transgender women. Oral presentation at: The Endocrine Society Annual Meeting; April 1\u20134, 2017; Orlando, FL."},{"key":"10.4158\/EP-2017-0116_bb0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/106002800103500902","article-title":"Acute hepatitis induced by cyproterone acetate","volume":"35","author":"Giordano","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP-2017-0116_bb0050","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.3748\/wjg.v12.i46.7551","article-title":"Hepatotoxicity induced by cyproterone acetate: a report of three cases","volume":"12","author":"Savidou","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.4158\/EP-2017-0116_bb0055","first-page":"37","article-title":"Oral spironolactone in post-teenage female patients with acne vulgaris: practical considerations for the clinician based on current data and clinical experience","volume":"5","author":"Kim","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.4158\/EP-2017-0116_bb0060","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1345\/aph.1G025","article-title":"Spironolactone for hirsutism in polycystic ovary syndrome","volume":"39","author":"Christy","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP-2017-0116_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01579291","article-title":"Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism","volume":"18","author":"Prior","year":"1989","journal-title":"Arch Sex Behav"},{"key":"10.4158\/EP-2017-0116_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4158\/EP.14.2.248","article-title":"Out of the shadows: it is time to mainstream treatment for transgender patients","volume":"14","author":"Safer","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2017-0116_bb0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-72-5-1008","article-title":"Comparison of sequential cyproterone acetate\/estrogen versus spironolactone\/oral contraceptive in the treatment of hirsutism","volume":"72","author":"O'Brien","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0116_bb0080","first-page":"73","article-title":"Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism","volume":"57","author":"Sert","year":"2003","journal-title":"Acta Med Okayama"},{"key":"10.4158\/EP-2017-0116_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(17)30068-2","article-title":"Transgender hormone therapy: understanding international variation in practice","volume":"5","author":"Mamoojee","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.4158\/EP-2017-0116_bb0090","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0116_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/obr.12282","article-title":"Testosterone and obesity","volume":"16","author":"Kelly","year":"2015","journal-title":"Obes Rev"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20353969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20353969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:04:44Z","timestamp":1761516284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20353969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1530891X20353969"],"URL":"https:\/\/doi.org\/10.4158\/ep-2017-0116","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2017-0116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}